Investors looking for safe havens in a dangerous market. China EV players, FedEx and Micron earnings next week.

The new administration’s decision to fire a tenth of the workers at the federal government agency that oversees mental and ...

Abzena, a San Diego-based CDMO and CRO focused on bioconjugates and complex biologics, has welcomed Taylor Boyd as its new ...

Allied Market Research published a report, titled, "Condom Market by Type (Latex, Non Latex), and Distribution Channel (Drug ...

Sutro Biopharma is undergoing a seismic shake-up —jettisoning its CEO, half of its workforce, its lead candidate and its ...

Amgen (AMGN) gains traction with a 26% YTD rise, strong earnings, and a robust dividend. Analysts signal growth potential ...

The Senate has until midnight Friday to pass a bill to keep the government open. Meantime, President Donald Trump will deliver what the White House calls a law-and-order speech on Friday at the ...

STRO-004: Sutro’s novel exatecan Tissue Factor ADC, has been prioritized as the Company’s lead program, with an initial focus in solid tumors. The Company is preparing to submit an IND in the second ...

A free account provides you access to a limited number of free articles each month, plus newsletters, job postings, salary ...

Reports say the PKK will likely convene in Iraq next month for a final decision on dissolution as veteran politician Devlet ...

Sutro will rapidly advance next-generation exatecan and dual-payload ADC programs; luveltamab tazevibulin development to be deprioritized as Sutro continues to seek a partner - - Three INDs for wholly ...